Breastfeeding research has accumulated one of the largest and most consistent bodies of evidence in infant health science, demonstrating benefits for infection resistance, allergy reduction, neurodevelopment, and maternal health — while also highlighting important nuances about duration and context.
What Does the Research Say?
A 2016 Lancet systematic review found breastfeeding reduced infant risk of respiratory infections by 72%, diarrheal illness by 64%, otitis media by 23%, and sudden infant death syndrome (SIDS) by 36%. Mechanistically, human breast milk contains immunoglobulins (primarily IgA), lactoferrin, oligosaccharides (HMOs), and live cells including stem cells and macrophages — a sophisticated immune transfer system that infant formula cannot replicate. HMOs specifically feed beneficial Bifidobacterium in the infant gut, establishing a protective microbiome that formula does not.
Neurodevelopmental benefits are more debated: a large RCT (PROBIT, n=17,000) showed exclusive breastfeeding significantly improved IQ scores by 5.9 points at age 6.5. However, sibling-comparison studies attempting to control for confounders show smaller effects, suggesting some benefits are partially attributable to maternal characteristics correlated with breastfeeding duration. For maternal health, breastfeeding is associated with a 26% reduced breast cancer risk, 37% reduced ovarian cancer risk, and significant protection against type 2 diabetes and cardiovascular disease, per the 2016 Lancet series.
Key Findings
- Lancet meta-analysis: breastfeeding reduces respiratory infections by 72%, diarrheal illness by 64%, SIDS by 36%
- Human milk oligosaccharides (HMOs) establish protective Bifidobacterium-dominant infant microbiome
- PROBIT RCT (n=17,000): exclusive breastfeeding improved IQ by 5.9 points at age 6.5
- Maternal benefits: 26% reduced breast cancer risk, 37% ovarian cancer risk reduction
Practical Takeaway
WHO and AAP recommend exclusive breastfeeding for 6 months, then continuation with complementary foods to 2 years or beyond. Breastfeeding challenges (latch issues, supply, pain) are addressable — a certified lactation consultant (IBCLC) in the first week dramatically increases breastfeeding duration. Formula supplementation does not inherently end breastfeeding — mixed feeding is a valid middle path for many families.